Social services
Kerryington P. Pedigo, a petitioner in the National Vaccine Injury Compensation Program, has been awarded compensation after filing a petition under the Vaccine Act. The petition alleged that Pedigo suffered a SIRVA as a result of an influenza vaccine received on November 17, 2021, and that she experienced residual effects
Social services
Deidre Bratton, a petitioning claimant under the National Vaccine Injury Compensation Program, received a decision awarding her compensation for a shoulder injury related to vaccine administration. Following the parties' stipulation, I issued a decision on January 30, 2025, awarding compensation to Petitioner. Petitioner has now filed a motion for
COVID-19
Eddie Gray, former President of GlaxoSmithKline Europe and former CEO of Dynavax Technologies Corp., has joined the Board of Directors at Botanical Solution Inc. (BSI). As a veteran pharmaceutical and vaccine industry executive, Gray will provide strategic guidance for BSI's future development. Gray's experience will be
COVID-19
Research conducted at Shandong First Medical University and Shandong Academy of Medical Sciences has found that cancer patients undergoing chemotherapy and radiotherapy are at a higher risk of contracting COVID-19. The retrospective cohort study evaluated the impact of cancer treatments on COVID-19 incidence and outcomes in 603 cancer patients, with
COVID-19
A first lieutenant in the Air Force Reserve has lost his lawsuit against the Air Force over its COVID-19 vaccine mandate under the Religious Freedom Restoration Act (RFRA). The 6th Circuit Court of Appeals ruled that the Air Force's sovereign immunity bars money damages claims, as the relief
COVID-19
U.S. Health Secretary Robert F. Kennedy Jr. has caused controversy with his sudden dismissal of the existing 17-member expert panel and the appointment of eight new replacements, including several anti-vaccine voices. The agenda for the new committee's first meeting, posted last Wednesday, has sparked concerns among health
Social services
Kathleen Burden, a petitioner, filed a petition under the National Vaccine Injury Compensation Program (NVICP) alleging a shoulder injury related to vaccine administration following an influenza vaccine she received on October 19, 2021. After the parties stipulated to a decision, Chief Special Master Corcoran issued a decision awarding compensation to
Social services
Chief Special Master Corcoran has issued a ruling on entitlement in the case of Maxfel Goodson v. Secretary of Health and Human Services, granting compensation to the petitioner under the National Vaccine Injury Compensation Program. The ruling states that Petitioner suffered a Table injury, shoulder injury related to vaccine administration
Social services
The United States Court of Federal Claims has issued an opinion awarding compensation to Sarah Whitman Blank under the National Vaccine Injury Compensation Program. On April 4, 2023, Blank filed a petition for compensation after receiving an influenza vaccine on October 24, 2021. The vaccine is listed in the Vaccine
Social services
Frances C. Nwokoro, a petitioner in the United States Court of Federal Claims, was awarded compensation for a shoulder injury related to vaccine administration. The court issued a decision on attorney's fees and costs, allocating $24,640.96 for the petitioner's counsel. This award consists of
Social services
Peter Cavanagh, as administrator of the Estate of Pamela Cavanagh, has received a settlement award of $62,000.00 in a National Vaccine Injury Compensation Program case. The case, No. 20-1742V, was filed on December 4, 2020, and alleged that Pamela Cavanagh suffered a shoulder injury related to vaccine administration
COVID-19
The mRNA vaccine core enzyme market is experiencing unparalleled growth, driven by the demand for rapid vaccine development and the increasing adoption of biotechnology. As of 2024, the market is valued at approximately USD 2.3 billion, with projections indicating it will reach nearly USD 7 billion by 2034, reflecting
